Nuvig, a biotech company cofounded by Jeffrey Ravetch, has launched phase two trials and raised $200 million.

The discovery could greatly improve patient experience and address supply shortages.

A newly identified molecular pathway shifts microglia into a protective state, and may lead to Alzheimer's therapies that can reprogram the brain’s own immune defenses.

The global effort, led by Rockefeller University, just made the most dangerous animal in the world a lot easier to study—and perhaps defeat one day.

Researchers have discovered the first evidence of what happens when a female mosquito chooses to mate for the one and only time in her life.

Scientists discovered that a subtle behavior by the female mosquito dictates whether mating is successful.

Scientists solve the long-standing mystery of how nuclear pore complexes make split-second decisions about which molecules to allow to pass through their molecular gates.

Greg Alushin is decoding how the body’s building blocks sense and respond to force, with implications for everything from cancer to developmental disorders.

Scientists have revealed a previously unknown form of ofaction gene regulation that may be broadly shared across insect species—opening up a new window into studying connections between genes and social behaviors.

By boosting a single protein, PI31, Rockefeller scientists restored a cleanup system in the brain—preventing neuronal degeneration and extending lifespan in flies and mice, and potentially pointing toward a new strategy for treating Alzheimer's and related disorders.